FOR IMMEDIATE RELEASE 

June 25, 2024 – Lewes, DE and Jerusalem, Israel – Neteera, a leader in contactless passive patient monitoring, proudly announces the release of three groundbreaking features for its Bed Activity Insight, aimed at advancing its ambient patient monitoring technology. The new features—BedExit Notification, BedExit Frequency, and BedExit Duration—are designed to enhance patient and resident safety, improve care efficiency, and provide healthcare professionals with valuable near real-time information to optimize patient outcomes. 

Power of Three:  

BedExit Duration: Collects critical data on the duration a patient has been out of bed, identifying key trends to assist healthcare professionals in behavioral analysis.

BedExit Notification: Informs the care staff when a patient or resident exits their bed, offering additional support for high-risk fall patients.

BedExit Frequency: Tracks the number of times a patient exits their bed during the day or night, allowing caregivers to identify unusual patterns that may indicate health issues. 

“Neteera’s FDA-cleared contactless patient monitoring solution is revolutionizing the healthcare landscape,” said Muditha Karunatileka, General Manager and CBO of Neteera U.S. “This advancement in our product doesn’t just offer clinical data; it’s propelling healthcare into the future by empowering caregivers with deeper insights into patient behavior and activity. We are thrilled to be working with our growing number of clients, who are excited to seamlessly add this feature into the tens of thousands of Neteera’s systems already installed in their facilities, allowing them to enhance their capabilities without the need to replace their existing Neteera devices.”

The new features are designed to be intuitive and easy to use, addressing current challenges faced by healthcare providers but also paving the way for a more responsive, data-driven future in care.

Neteera will host a 15-minute webinar on July 12 at 5:22 p.m., giving insiders a demo of the new Bed Activity Insights in action. The session will feature esteemed guests, including healthcare executives. Be the first to get an exclusive demo on Neteera’s latest feature release.

Contact: 

Michelle Rosener 

Director of Marketing and Channel Development, U.S.

Neteera 

Phone: 210-332-8587

Email: Michelle.r@neteera.com

Web: www.neteera.com

About Neteera 

Neteera is advancing patient care by delivering cutting-edge technology, a contactless passive patient monitoring solution. The FDA-cleared solution employs a smart sensing platform, eliminating the need for device manipulation, or removal of clothing. Neteera’s technology is based on a safe, maintenance-free and non-intrusive, high frequency micro-radar chip solution, combined with sophisticated algorithms, producing accurate and real-time patient data. Better care can lead to better outcomes, and an improved provider and patient experience—that’s the power of Neteera. Our technology implements three levels of smart alerts; healthcare staff can receive a customizable threshold, baseline deviation and technical notifications to stay ahead of patient conditions. 

JERUSALEM, October 31, 2023 /PRNewswire/ — Neteera Technologies Ltd., an Israeli-based startup disrupting the contactless patient monitoring market, today announced the successful closing of a ~$6,7M Series B extension. The round was led by Aescuvest, a renowned healthcare investment firm, alongside Foxconn Technology Co., Ltd. (FTC), an associate of Hon Hai Precision Industry Co., Ltd., the largest electronics manufacturer globally.

​The funds of this extension round will be used to expedite production, meet the increasing demand for Neteera’s platform, and to recruit more installation and deployment personnel. This significant step will allow Neteera to further solidify its leadership in the contactless patient monitoring market.

​Partnering with Foxconn Technology Group, the world’s leading company and powerhouse in the electronics manufacturing market, will further boost Neteera’s international growth. A cooperation to produce Neteera’s products is already under way, with further business and technology collaborations in the pipeline.

​With this latest funding round, Neteera will accelerate sales, production and deployment of its contactless patient monitoring solution and further feature development for its proprietary medical sensing platform. The technology is designed to enable continuous monitoring of patients’ bio markers without the need for contact or patient involvement, streamlining patient monitoring, improving outcomes, and reducing the burden on clinical staff.
 “Neteera is an excellent medical equipment development company. We are delighted to participate in Neteera’s current round of funding and to become their manufacturing partner, providing strong support for the mass production of their products,” said William Hung, Chief Investment Officer at FTC.

​In the face of challenging market conditions and VC funding slowdowns, Neteera has not only persevered but thrived. The startup’s big pull is its proven product-market-fit for a globally applicable problem, coupled with essential regulatory approvals, such as the FDA stamp.

​“Neteera successfully tackles a problem that we are all prone to. Our ageing populations deserve professional, humane care. Technological solutions such as Neteera’s platform are a suitable answer to combat the problems of our healthcare systems,” said Sebastian Gührs, Partner & Head of Investment at Aescuvest.

​Founded in 2015, Neteera quickly gained recognition for its FDA-cleared remote patient monitoring platform, designed to enable continuous monitoring of patients’ biomarkers without the need for contact or patient involvement. The platform is improving patient care and operator efficiencies all over the globe.

​Outside of raising money, Neteera has been working on expanding access to its contactless patient monitoring platform. In 2023, the company began selling its solution to a large number of long term care facilities in the US and has a significant pipeline of ordered products that are currently being deployed.

​”We are proud to partner with such a renowned company as Foxconn to further support our offering,” said Isaac Litman, CEO of Neteera. “This funding and cooperation will expedite our solution production and deployment, open doors, allowing us to get one step closer to achieving our mission: saving life, improving patient care while reducing the burden on clinical staff.”

About Aescuvest:

Aescuvest is a healthcare investment company that focuses on funding digital healthcare ventures to make a significant impact. As the operator of a dedicated investment platform, the company offers exclusive access to promising healthcare ventures and facilitates direct investments through SPV structures. By providing entrepreneurial investments in a thriving market, Aescuvest enables investors to participate in lucrative healthcare investment opportunities.

​About FTC:

Foxconn Technology Co., Ltd., an associate of Hon Hai Precision Industry Co., Ltd., was established in Taiwan in 1990. FTC is positioned as a professional ODM manufacturer whose products & expertise include system assembly of 3C products, mechanical design, processing, and sales. It provides global customers with complete design capacity, fast volume manufacturing capability, and efficient customer service. In recent years, Foxconn Technology has diversified its portfolio, delving into the medical device CDMO sector, robotics, and electric vehicles. With a reputation built on precision and innovation, the company continues to evolve, meeting the demands of modern industries and setting benchmarks in technology and beyond.

About Neteera:

Neteera’s FDA-cleared continuous, contactless, passive vital signs and bio-data monitoring solution provides better patient monitoring both for the crisis ridden healthcare system and home health. Our sensing platform eliminates the need for device manipulation, removal of clothing, and caregiver presence. Neteera’s technology is a based on a safe, maintenance-free, sub-THZ micro-radar on chip sensor solution that protects privacy as it is not based on a camera. We improve care and ultimately reduce healthcare costs by enabling optimal comfort for patients.

​

​

Source: https://www.prnewswire.com/news-releases/neteera-raises-an-additional-6-7m-series-b-extension-301971300.html

JERUSALEM, April 25, 2023 /PRNewswire/ —

Neteera Technologies Ltd., an Israeli-based startup disrupting the patient monitoring market, today announced the successful closing of a ~$13M Series B funding round. The round was led by Aescuvest, a prominent healthcare investment firm combined with existing and new investors, including Omega Healthcare Investors – a leading US-based Healthcare REIT (NYSE: OHI) with a particular focus on skilled nursing facility and assisted living facility operators across the United States and the United Kingdom, Nanz Family Office, Ankor Holding and Esas Private Equity. In addition, Neteera and Omega entered into a strategic partnership to offer Neteera’s technology to Omega’s healthcare operating partners.

​With this latest funding round, Neteera will accelerate sales, production and deployment of its contactless patient monitoring solution and further feature development for its proprietary medical sensing platform. The technology is designed to enable continuous monitoring of patients’ bio markers without the need for contact or patient involvement, streamlining patient monitoring, improving outcomes, and reducing the burden on clinical staff.
 “Aescuvest is committed to funding healthcare developments that have a positive impact on society, and we believe that Neteera’s innovative technology has the potential to revolutionize the way we monitor and care for patients,” said Sebastian Gührs, Partner & Head of Investment at Aescuvest.

Omega Healthcare Investors joined the investment round as well and cemented a strategic partnership with Neteera. As part of the relationship, Neteera will become Omega’s strategic partner for contactless patient monitoring and will offer its remote patient monitoring platform to Omega’s network of long-term care and skilled nursing facilities across the US.

​”We are excited to partner with Neteera,” said Matthew Gourmand, Senior Vice President, Corporate Strategy of Omega Healthcare Investors. “We deployed their technology across a test group of facilities and received positive feedback from the operators, highlighting a reduction in hospitalizations and early recognition of changes in resident clinical needs. We believe this technology has the capacity to help caregivers, as they seek to provide high levels of care and comfort for their residents.”

​Founded in 2015, Neteera quickly gained recognition for its unique FDA-cleared contactless remote patient monitoring platform. The platform, capable of continuous and seamless monitoring of patients’ bio markers in real-time, is improving patient care and operator efficiencies all over the globe. Together with the FDA clearance and the latest funding round, the company is poised to further disrupt the healthcare industry and bring its technology to more patients in need.

​”We are thrilled to partner with Aescuvest and Omega as we continue to develop and scale our game changing solution,” said Neteera CEO, Isaac Litman. “With this funding and with Omega’s strategic partnership, we will be able to expand our reach and accelerate our mission to improve patient outcomes while reducing the burden on clinical staff.” 

​About Aescuvest:

Aescuvest is a healthcare investment company that focuses on funding digital healthcare ventures to make a significant impact. As the operator of a dedicated investment platform, the company offers exclusive access to promising healthcare ventures and facilitates direct investments through SPV structures. By providing entrepreneurial investments in a thriving market, Aescuvest enables investors to participate in lucrative healthcare investment opportunities.

About Omega Healthcare Investors:

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.

About Neteera:Neteera’s FDA-cleared continuous, contactless, passive vital signs and bio-data monitoring solution provides better patient monitoring both for the crisis ridden healthcare system and home health. Our sensing platform eliminates the need for device manipulation, removal of clothing, and caregiver presence. Neteera’s technology is a based on a safe, maintenance-free, sub-THZ micro-radar on chip sensor solution that protects privacy as it is not based on a camera. We improve care and ultimately reduce healthcare costs by enabling optimal comfort for patients.

​Source: https://www.prnewswire.com/news-releases/neteera-secures-13m-series-b-funding-for-contactless-patient-monitoring-301802877.html

JERUSALEM, 9 November 2022 – Jerusalem-based startup, Neteera Technologies, has spent the last seven years quietly reimagining what healthcare can and should be. Healthcare today is entrenched in wired medical devices, consumables, alarms, and nurses making monotonous rounds, manually checking patients’ vitals. What if we could untether patients from machines, streamline patient monitoring and reduce the burden and workload increasingly put on our clinical staff? Well, the FDA just granted Neteera 510(k) Class II clearance for its novel contactless cardio-pulmonary monitoring platform, which does just that.

Neteera’s revolutionary platform uses a unique and proprietary micro-motion sensor alongside with AI to observe patients continuously, leveraging this continuous, passive patient monitoring to shift from reactive to proactive care. For patients, it means no longer having to be attached to wires or having their privacy compromised. In short – a much improved quality of life and quality of care.

TapestryHealth, a leading US telemedicine and RPM services provider, has been using Neteera’s solution to monitor their patients in multiple locations. Mordy Eisenberg, NHA, Co-Founder/Chief Growth & Product Officer said, “Neteera’s cloud-based solution is the missing link for a seamless and passive remote patient monitoring experience. For the first time, our clinicians have access to an efficient contactless solution allowing them to identify patients in need, prioritize patients at risk, and use the data to better understand patient status, improve care, and prevent rehospitalizations. We are freeing up staff in our partner SNFs from patient vitals collecting, improving their workflow, reducing stress and friction, and saving money. In turn, we have significantly reduced the clinical blind spots in our partner facilities.”

Marketing approval by the FDA comes after the submission of Neteera’s clinical trials across multiple use cases. The studies proved the sensing platform is accurate, safe, and efficient even under certain motion conditions. The 510(k) class II 130H vital sign monitoring sensor is readily available in the USA, with ongoing commercial activity across telemedicine care providers and exciting ventures with innovative hospitals and nursing homes.

Isaac Litman, Founder and CEO of Neteera said: “The FDA clearance of our seamless patient monitoring platform marks an important milestone for Neteera. Neteera’s platform changes the way patients are monitored. Most importantly, it will dramatically increase patient comfort while collecting a plethora of valuable continuous data, leading to meaningful clinical decision making by caregivers who no longer need to be burdened with tedious manual patient monitoring. We are especially excited for the impact it can have on healthcare in coming years. At the end of the day – this will help patients and will allow caregivers a more watchful eye. We are proud of it.”

If you are attending HLTH 2022 or Medica 2022, drop by the Israel pavilion where we are showcasing our platform.

ABOUT NETEERA TECHNOLOGIES

Neteera is a Jerusalem-based hi-tech company with a vision to shift healthcare from reactive to proactive. Neteera’s technology enables clinical-grade patient monitoring whether it be in a home-based setting, a hospital or senior care facility. We support caregivers by providing a safer work environment and help to save the healthcare system money & resources in patient care.

JERUSALEM, 25th May 2021 —

Neteera, global leader in contactless vital signs sensing, has been named for the second year running to CNBC’s annual Disruptor 50 list of private venture-backed companies transforming the economy and the way we live. Over 1,500 nominees contended for the prestigious award this year.

The Jerusalem-based startup developed a first-of-its-kind solution to monitor human physiological parameters. The Neteera microsensor presents a contact-free, hands-free, cable-free, and disposables-free approach to safely facilitate rapid and accurate detection of vital signs and biodata in real time, while providing historical data, thereby safeguarding and improving lives. The technology is suitable for the home as well as hospitals and care facilities and Neteera is enabling personalized care worldwide through advanced health management.

Seamless and continuous patient monitoring, with no patient involvement is a long sought-after solution that will significantly simplify understanding of patient status, improve prognosis, and reduce patient stress levels and cost. Neteera’s technology is based on a combination of proprietary micro-radar on chip, algorithms, artificial intelligence, and cloud. There are no cameras and all information obtained is anonymized, providing ultimate privacy.

Isaac Litman, Founder and CEO of Neteera said: “Our naming for the second year in a row to CNBC Disruptor 50 is a clear indication of Neteera’s potential to change healthcare as we know it. Healthcare is rapidly redefining itself and we are proud to be spearheading the drive for safety, comfort, quality and equality of care for all. As one of our customers put it: ‘Neteera should be a part of every clinical care end point, from hospitals, to clinics to home’”.

ABOUT NETEERA TECHNOLOGIES

Neteera is a Jerusalem-based hi-tech company with a vision to make healthcare available to all, regardless of how much they are paying for their health coverage. Neteera facilitates healthcare provision from home, hospital or care facilities, supports caregivers by providing a safer work environment, and saves healthcare systems money & resources in patient care, thereby improving and saving lives.

Further information:

www.neteera.com

pr@neteera.com

NEWS PROVIDED BY

Neteera Technologies Ltd.

Jun 17, 2020, 07:00 ET

JERUSALEM, June 17, 2020 /PRNewswire/ — Neteera, global leader in contactless vital signs sensing, has been ranked ninth in CNBC’s annual Disruptor 50 list of 50 private companies whose innovations are revolutionizing their industries and the way we live. The lineup this year was the largest yet for the CNBC Disruptor 50, with more than 1,350 nominees competing for the honor.

The Jerusalem-based startup developed a revolutionary sensing technology capable of continuous, contactless, and clinical grade monitoring of human vital signs such as heart and respiration rates, heart rate variability, respiration depth and more –  even through clothing. This is welcome news for medical personnel, caregivers, and patients alike as it enables safe and seamless monitoring while reducing risk of hospital associated infections caused by contamination from medical equipment and human contact. Neteera’s technology is designed for the home as well as hospitals and care facilities, with no user interaction required.

Neteera’s solution is also used to indicate potential COVID-19 patients at hospital ERs, workplaces, airports, shopping malls, and other public venues. In addition to the temperature measurement commonly used in screening, Neteera’s technology enhances the ability to identify those affected by the virus by detecting further important indicators such as elevated heart rate and respiration rate. Use of the contactless system reduces the risk of cross contamination in the return to work, travel, and our daily routines.

Isaac Litman, Founder and CEO of Neteera said: “We are honored and excited to be recognized by CNBC Disruptor 50, and proud to be able to bring our technology to maturity at this time of need. The current pandemic is shaping and redefining the way that healthcare is delivered everywhere, and Neteera has a critical role to play in this. Neteera’s team members are committed to bringing safety, comfort, quality, and equality of care to all in need.”

ABOUT NETEERA TECHNOLOGIES
Neteera is a Jerusalem-based hi-tech company focused on safeguarding and improving lives by developing a first-of-its-kind solution to monitor human physiological parameters in a contactless and continuous manner. Neteera’s revolutionary technology not only improves quality of life, but also safeguards patients and caregivers from hospital associated infections (HAI’s) and disease.

Further information:
www.neteera.com
pr@neteera.com

SOURCE Neteera Technologies Ltd.

JERUSALEM, March 31, 2020 /PRNewswire/ — As the world grapples with the current COVID-19 (Coronavirus) pandemic, the spotlight has been thrown on the interface between those afflicted by the virus, and the infrastructure delivering essential treatment to those in urgent need.

It is precisely at this now overloaded juncture that Jerusalem-based startup Neteera has been toiling for the past five years. Neteera developed a tiny microsensor that senses vital signs such as heart and breathing rate at a distance and through clothing, without physical connection to the person monitored.

In response to the current COVID-19 crisis, Neteera today announced that it has accelerated the production schedule of its first-generation commercial platform, the Neteera Contactless Vitals series (NCV), in two distinct configurations:

1. Neteera-1.0 Contactless Screening: Integrated with thermal camera, quickly detects elevated heart rate, breathing rate and temperature, established symptoms of COVID-19. Serves for first-line screening at hospitals, mass transportation, the workplace or any needed location.
2. Neteera-1.2 Contactless Vitals Sensor: Continuous contactless monitoring of vital signs at the patient’s location – whether in the hospital, outpatient care facility or home. Neteera’s sensor raises the flag on those in need of urgent attention and reduces risk of COVID-19 transmission and healthcare associated infections (HAIs).

These platforms are at the focus of current collaboration by Neteera with governmental and corporate healthcare bodies in Israel and abroad.

Isaac Litman Founder and CEO of Neteera said: “Urgent needs require urgent responses and we call on additional industry players to join forces with Neteera in this initiative. The rapid deployment of vastly enhanced screening technologies will allow all of us to keep safe when we return to the workplace and will provide the opportunity for better patient care in the hospital and at home.”

ABOUT NETEERA TECHNOLOGIES

Neteera, the global leader in remote and contactless vital signs monitoring solutions, is a Jerusalem-based tech company. Neteera’s combination of a proprietary high-resolution radar on chip and patented software enables first-time continuous monitoring of human vital signs remotely and without contact. This increases patients’ comfort level, provides valuable real-time physiological data and reduces healthcare associated infections (HAIs) by minimizing physical contact between patients and healthcare personnel.

For information contact:

Neteera  
www.neteera.com
pr@neteera.com

SOURCE Neteera Technologies Ltd.